Back to search

France· FR:63857729

CERVAGEME 1 mg, ovule

A gemeprost product containing géméprost, registered in France by SANOFI WINTHROP INDUSTRIE. The same ATC class is registered in 3 of our 19 countries.

ATC G02AD03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCERVAGEME 1 mg, ovuleATCG02AD03REGISTER NO.FR:63857729PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Gemeprost is registered in 3 of 19 countries.

Countries holding a registration under ATC G02AD03 (gemeprost), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 2 of them publish a price we can compare per daily dose

Gemeprost · ATC G02AD03

3 / 19 countries

  • Finlandprice
  • Franceprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
GÉMÉPROST
Manufacturer
SANOFI WINTHROP INDUSTRIE
Country
France (FR)
ATC code
G02AD03
ATC class
Gemeprost
Defined daily dose
1 mg, V
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400932730469
    plaquette(s) thermoformée(s) PVC acétate de polyvinyle aluminium polyéthylène de 1 ovule(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Gemeprost in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gemeprost products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e9ce8bcb-5c67-406e-a3fc-8fd8561032af
GET /v1/drugs/e9ce8bcb-5c67-406e-a3fc-8fd8561032af?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63857729",
  "date_amm": "1984-07-17",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "GÉMÉPROST",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation abrogée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "ovule",
  "voies_administration": "vaginale",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about gemeprost.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.